Navigation Links
Insulet Establishes Eco-Friendly Disposal Program for the OmniPod(R) Insulin Management System
Date:7/8/2009

BEDFORD, Mass., July 8 /PRNewswire-FirstCall/ -- Insulet Corporation (Nasdaq: PODD), the leader in tubing-free insulin pump technology, announced today that the Company is introducing an environmentally friendly disposal program for its OmniPod(R) Insulin Management System. The Eco-Pod program will reduce the impact of used Pods on the environment, preventing hazardous waste from unnecessarily entering landfills. It is the industry's first program for the environmentally safe disposal of insulin pump components.

"People with diabetes shouldn't have to choose between taking care of their health and taking care of the environment," said Duane DeSisto, president & chief executive officer of Insulet. "We are proud to offer our customers the first environmentally safe disposal program in the insulin pump industry. The OmniPod System makes diabetes a smaller part of life and now it will have a smaller impact on the environment."

The Eco-Pod Program provides OmniPod customers an easy way to reduce their impact on the environment. Following procedures for bio-hazardous waste, the Pods are disassembled and metals are removed and recycled. The remaining components are then pulverized. The process takes hazardous waste that might leach into the ground water out of the waste stream; it also greatly reduces the volume of materials that are consigned to a landfill.

To participate, customers simply log on to MyOmniPod.com to pre-register. Insulet will pay for the costs associated with the disposal process, while program participants are responsible for shipping costs, which are less than $3 per month. Beginning August 1, a Pod Disposal Kit will be included with each Pod re-order. The kit includes all the tools customers need to do their part: a bag for collecting used Pods, a special pre-paid, pre-addressed bio-hazard shipping envelope and an instruction sheet. Every three months, participating customers return their used Pods in the shipping envelope. The first 2,000 customers to enroll in the Eco-Pod program will receive a free, limited-edition eco-friendly tote bag.

About the OmniPod Insulin Management System

The OmniPod Insulin Management System is the world's only tubing-free insulin pump. OmniPod offers people living with insulin-requiring diabetes all the benefits of insulin pump therapy, with unprecedented freedom, comfort and ease. OmniPod has just two components: the small, discreet, watertight Pod, worn almost anywhere on the body to hold and deliver insulin; and the PDM (Personal Diabetes Manager), a hand-held device that communicates wirelessly to program the Pod, calculates suggested doses and has a built-in FreeStyle(R) blood glucose meter.

About Insulet Corporation

Insulet Corporation is an innovative medical device company dedicated to improving the lives of people with diabetes. The Company's OmniPod Insulin Management System is a revolutionary, discreet and easy-to-use insulin infusion system that features two easy-to-use parts with no tubing and fully-automated cannula insertion. Through the OmniPod System, Insulet seeks to expand the use of insulin pump therapy among people with insulin-dependent diabetes. Founded in 2000, Insulet is based in Bedford, MA.

    Media Contact:
    Darcy Keane, Lazar Partners for Insulet Corporation
    Tel. 646-871-8487
    E-mail: dkeane@lazarpartners.com


'/>"/>
SOURCE Insulet Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Insulet Applauds Employee for Bronze Medal Performance in World Blind Sailing Championships
2. Insulet Receives CE Mark for the OmniPod(R) Insulin Management System
3. Insulet Corporation to Report First Quarter 2009 Financial Results on Thursday, May 7, 2009
4. Insulet Receives $60 Million Funding Commitment
5. Insulet Reports Fourth Quarter and Year End 2008 Results
6. Insulet Corporation to Report Fourth Quarter and Full Year 2008 Financial Results on Thursday, March 5, 2009
7. Insulet Corporation to Present at the J.P. Morgan Healthcare Conference on January 14, 2009
8. Insulet Reports Third Quarter 2008 Results
9. Insulet Announces Sponsorship of International Diabetes Federations World Diabetes Day Campaign
10. Sally W. Crawford Joins Insulets Board of Directors
11. Insulet Corporation to Report Second Quarter 2008 Financial Results on Tuesday, August 12, 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... ... 2017 , ... Ushio America proudly introduces the new ... solution for F32T8 fluorescent lamps on most instant-start and programmed-start electronic ballasts so ... lamps utilize the existing electronic ballast, saving labor and maintenance costs. It’s easy ...
(Date:4/28/2017)... Md. (PRWEB) , ... April 28, 2017 , ... ... Association of America (UCAOA) and College of Urgent Care Medicine will host industry ... workshops, sessions and speakers will help those in the industry adapt to the ...
(Date:4/28/2017)... ... April 28, 2017 , ... Researchers at ... ActiGraph’s CentrePoint Data Hub in a sample of participants enrolled in ... activity and sleep monitoring solutions for the global scientific community. The company’s new ...
(Date:4/28/2017)... ... 28, 2017 , ... Rob Lowe is a popular actor that has been ... to an educational purpose as the host of the “Informed” series. The program focuses ... recent episode, the series focuses on thyroid cancer. , Although thyroid cancer is an ...
(Date:4/27/2017)... ... April 27, 2017 , ... Healthcare companies are trying ... will rapidly reject an outdated healthcare executive resume. , “If you’re a healthcare executive ... executive resume and wondering if it’s as ready as you are for a new ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... WOONSOCKET, R.I. , April 20, 2017 /PRNewswire/ ... (NYSE: CVS), today unveiled a new store design ... new assortment of healthier food, health-focused products and ... the store to help customers discover new offerings. ... represent the next evolution of the customer experience ...
(Date:4/20/2017)... April 20, 2017 NeuroVive Pharmaceutical AB ... announced positive preclinical results demonstrating anti-fibrotic effects ... non-alcoholic steatohepatitis (NASH), in an additional well-validated ... NV556 has previously shown similar anti-fibrotic effects ... NeuroVive,s scientists present novel data demonstrating anti-fibrotic ...
(Date:4/19/2017)... , April 19, 2017  IRIDEX Corporation (Nasdaq: ... financial results for the first quarter 2017 after the ... Company,s management team will host a corresponding conference call ... Investors interested in listening to the conference ... domestic callers or (703) 326-3030 for international callers, using ...
Breaking Medicine Technology: